Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
Lists
Only you see this
Abstract
Surgical resection represents the only curative treatment option for patients with biliary tract cancer, but not all patients benefit to the same extent in terms of overall survival. Here, we provide evidence that serum levels of an inflammatory mediator (suPAR) are indicative of a patient's postoperative outcome and might thus help to identify the ideal surgical candidates.
BibTeX
@inproceedings{loosen2020circulating,
author = {Sven H. Loosen and Annemarie Breuer and Frank Tacke and Jakob Nikolas Kather and Joao Gorgulho and Patrick H. Alizai and Jan Bednarsch and Anjali A. Roeth and Georg Lurje and Sophia M. Schmitz and Jonathan F. Brozat and Pia Paffenholz and Mihael Vucur and Thomas Ritz and Alexander Koch and Christian Trautwein and Tom Florian Ulmer and Christoph Roderburg and Thomas Longerich and Ulf P. Neumann and Tom Luedde},
title = {{Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer}},
booktitle = {JHEP},
year = {2020},
doi = {10.1016/j.jhepr.2020.100080},
}Loading related content...